Close examination of the methylation status of RASSF1A reveals that hypermethylation occurs in the promoter and exon 1 region in a large percentage of human breast cancers [10], but the distinct location of the methylated CpGs are differentially distributed among different tumors [11]. The gene discussed is RASSF1; the disease is breast cancer.